Schistosomiasis is an old and geographically widespread parasitic disease that severely damages human health and affects socioeconomic development in China. The implementation of the integrated strategy with emphasis on controlling the source of infection and the (20042015) greatly facilitated the progress towards the elimination of schistosomiasis in China. Since transmission control of schistosomiasis was achieved in 2015, the goal of the national schistosomiasis control program has moved to transmission interruption and elimination in China. Because of the impacts of natural and social factors, and the new situation, new task and new demands following the continuous decline in the endemic situation of schistosomiasis, several challenges exist to achieve the goal of schistosomiasis elimination nationwide. This paper analyzed the current endemic status of schistosomiasis, progress and challenges of schistosomiasis elimination, and proposed some suggestions for the national chistosomiasis elimination program in China.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.16250/j.32.1374.2018249 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
African schistosomes in small mammal communities: Perspectives from a spatio-temporal survey in the vicinity of Lake Guiers, Senegal.
PLoS Negl Trop Dis
December 2024
CBGP, IRD, CIRAD, INRAE, Institut Agro, Université de Montpellier, Montpellier, France.
Schistosomiasis is a neglected tropical disease of public health significance. In view of its elimination as a public health problem by 2030, adopting a One Health approach is necessary, considering its multidimensional nature. Animal reservoirs, in particular, pose a significant threat to schistosomiasis control in Africa and beyond.
View Article and Find Full Text PDFContextual factors influencing schistosomiasis treatment and identification of delivery platforms for arpraziquantel in hard-to-reach areas and populations in Homa Bay County, Kenya.
PLOS Glob Public Health
December 2024
Swiss Tropical and Public Health Institute, Allschwil, Switzerland.
A new formulation of praziquantel, arpraziquantel (arPZQ), has been developed for preschool-aged children (PSAC) to fill the treatment gap for this age group in schistosomiasis control and elimination programs. There is now a priority to ensure that the drug reaches all at-risk PSAC in endemic areas, including hard-to-reach areas and populations. This study aimed to determine schistosomiasis treatment-related contextual factors among fishermen and island populations in Homa Bay County, Kenya, and to identify a suitable platform to deliver arPZQ.
View Article and Find Full Text PDFGlobal trends of schistosomiasis burden from 1990 to 2021 across 204 countries and territories: Findings from GBD 2021 study.
Acta Trop
December 2024
National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute of Parasitic Diseases at Chinese Center for Disease Control and Prevention (Chinese Center for Tropical Diseases Research), NHC Key Laboratory of Parasite and Vector Biology, WHO Collaborating Centre for Tropical Diseases, National Center for International Research on Tropical Diseases, Shanghai 200025, China; School of Global Health, Chinese Center for Tropical Diseases Research, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China. Electronic address:
Introduction: The WHO aims to eliminate schistosomiasis as a public health problem by 2030. Based on the Global Burden of Disease 2021 (GBD 2021), this study assesses the global distribution of schistosomiasis burden to guide policy and resource allocation.
Methods: Schistosomiasis burden and social-demographic indexes (SDIs) data were extracted from GBD 2021 study.
Barriers and facilitators to programmatic mass drug administration in persistent schistosomiasis hotspot communities: An ethnographic study along Lake Albert, midwestern Uganda.
PLoS Negl Trop Dis
December 2024
Department of Pathology, University of Cambridge, Tennis Court Road, Cambridge, United Kingdom.
Background: The WHO Neglected Tropical Disease Roadmap for 2021-2030 includes the goal of eliminating schistosomiasis as a public health problem in all endemic countries. Despite heightened efforts since 2012, critical action is still required in addressing barriers to Mass Drug Administration, the primary control method. This includes improvement in adherence by the populations in persistent schistosomiasis hotspots.
View Article and Find Full Text PDFMathematical model of voluntary vaccination against schistosomiasis.
PeerJ
December 2024
Department of Mathematics and Applied Mathematics, Virginia Commonwealth University, Richmond, VA, United States of America.
Article Synopsis
- Human schistosomiasis, caused by Schistosoma worms, is a neglected tropical disease prevalent in sub-Saharan Africa, currently lacking a vaccine despite ongoing development.
- The study improves a compartmental model of schistosomiasis by adding human behavior and voluntary vaccination factors, highlighting that effective herd immunity requires specific vaccination rates.
- Results show that unless vaccination costs are low, voluntary vaccination alone may not sufficiently lower disease prevalence below 1%, emphasizing the need for affordable vaccine access to achieve public health goals.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!